There have been 50 recent insider transactions recorded for Sigilon Therapeutics, Inc. (SGTX), including 33 buys and 15 sells. Total insider buying was valued at $29.49M and total insider selling at $3.07M.
Notable insiders with recent activity include Oesterle Stephen N., Ruffolo Robert R, Cole Douglas G.. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — SGTX
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2023-08-11 |
Oesterle Stephen N. |
Director |
Return of Shares |
4,273 |
$7.41 |
$31.66K |
- |
| 2023-08-11 |
Ruffolo Robert R |
Director |
Return of Shares |
3,754 |
$7.41 |
$27.82K |
- |
| 2023-08-11 |
Cole Douglas G. |
Director |
Return of Shares |
683 |
$8.28 |
$5.65K |
- |
| 2023-08-11 |
Cox John |
Director |
Return of Shares |
683 |
$9.92 |
$6.78K |
- |
| 2023-08-11 |
Vivaldi Coelho Rogerio |
President and CEO |
Return of Shares |
35,382 |
$14.17 |
$501.36K |
- |
| 2023-08-11 |
Shaff Eric D. |
Director |
Return of Shares |
683 |
$9.92 |
$6.78K |
- |
| 2023-08-11 |
Patel Kavita |
Director |
Return of Shares |
683 |
$9.92 |
$6.78K |
- |
| 2023-08-11 |
Kowalsky Matthew Paul |
Chief of Staff and CLO |
Return of Shares |
1,925 |
$14.92 |
$28.72K |
- |
| 2023-08-11 |
Ashton-rickardt Philip |
Chief Scientific Officer |
Return of Shares |
8,845 |
$14.17 |
$125.33K |
- |
| 2023-08-11 |
Pontes Josias |
Chief Financial Officer |
Return of Shares |
10,767 |
$14.17 |
$152.57K |
- |
| 2023-08-11 |
Yuan Qing Sarah |
Ctoo |
Return of Shares |
8,846 |
$14.17 |
$125.35K |
- |
| 2023-08-11 |
Eli Lilly & Co |
10 Percent Owner |
Informative Buy |
1,718,493 |
$14.92 |
$25.64M |
100 |
| 2023-08-11 |
Flagship Ventures Fund V General Partner Llc |
10 Percent Owner |
Tender Offer (Sell) |
113,960 |
$14.92 |
$1.7M |
- |
| 2023-07-27 |
Yuan Qing Sarah |
Ctoo |
Option Exercise |
2,884 |
$19.24 |
$55.49K |
2,884 |
| 2023-07-21 |
Vivaldi Coelho Rogerio |
President and CEO |
Option Exercise |
5,528 |
$19.24 |
$106.36K |
11,963 |
| 2023-07-21 |
Pontes Josias |
Chief Financial Officer |
Option Exercise (Sell) |
1,444 |
$19.24 |
$27.78K |
3,171 |
| 2023-06-28 |
Eli Lilly & Co |
10 Percent Owner |
Disposition |
- |
- |
- |
211,110 |
| 2023-05-19 |
Oesterle Stephen N. |
Director |
RSU Award |
8,888 |
$0.64 |
$5.66K |
8,888 |
| 2023-05-19 |
Ruffolo Robert R |
Director |
RSU Award |
8,888 |
$0.64 |
$5.66K |
8,888 |
| 2023-05-19 |
Cole Douglas G. |
Director |
RSU Award |
8,888 |
$0.64 |
$5.66K |
8,888 |
| 2023-05-19 |
Cox John |
Director |
RSU Award |
8,888 |
$0.64 |
$5.66K |
8,888 |
| 2023-05-19 |
Shaff Eric D. |
Director |
RSU Award |
8,888 |
$0.64 |
$5.66K |
8,888 |
| 2023-05-19 |
Patel Kavita |
Director |
RSU Award |
8,888 |
$0.64 |
$5.66K |
8,888 |
| 2023-02-28 |
Vivaldi Coelho Rogerio |
President and CEO |
RSU Award |
460,000 |
$1.09 |
$501.4K |
460,000 |
| 2023-02-28 |
Kowalsky Matthew Paul |
Chief of Staff and CLO |
Disposition |
77,777 |
$4.12 |
$320.44K |
- |
| 2023-02-28 |
Kowalsky Matthew Paul |
Chief of Staff and CLO |
RSU Award |
165,000 |
$1.09 |
$179.85K |
165,000 |
| 2023-02-28 |
Ashton-rickardt Philip |
Chief Scientific Officer |
RSU Award |
115,000 |
$1.09 |
$125.35K |
115,000 |
| 2023-02-28 |
Pontes Josias |
Chief Financial Officer |
RSU Award |
140,000 |
$1.09 |
$152.6K |
140,000 |
| 2023-02-28 |
Yuan Qing Sarah |
Ctoo |
RSU Award |
115,000 |
$1.09 |
$125.35K |
115,000 |
| 2022-05-26 |
Oesterle Stephen N. |
Director |
RSU Award |
8,888 |
- |
- |
8,888 |
| 2022-05-26 |
Ruffolo Robert R |
Director |
RSU Award |
8,888 |
- |
- |
8,888 |
| 2022-05-26 |
Cole Douglas G. |
Director |
RSU Award |
8,888 |
$0.76 |
$6.78K |
8,888 |
| 2022-05-26 |
Cox John |
Director |
RSU Award |
8,888 |
$0.76 |
$6.78K |
8,888 |
| 2022-05-26 |
Shaff Eric D. |
Director |
RSU Award |
8,888 |
$0.76 |
$6.78K |
8,888 |
| 2022-05-26 |
Patel Kavita |
Director |
RSU Award |
8,888 |
$0.76 |
$6.78K |
8,888 |
| 2022-05-26 |
Story Brooke |
Director |
RSU Award |
8,888 |
- |
- |
8,888 |
| 2022-04-01 |
Yuan Qing Sarah |
Ctoo |
RSU Award |
120,000 |
- |
- |
120,000 |
| 2022-03-07 |
Yuan Qing Sarah |
Officer |
Unknown |
- |
- |
- |
- |
| 2022-02-18 |
Vivaldi Coelho Rogerio |
President and CEO |
RSU Award |
230,000 |
$1.48 |
$340.4K |
230,000 |
| 2022-02-18 |
Ashton-rickardt Philip |
Chief Scientific Officer |
RSU Award |
90,000 |
$1.48 |
$133.2K |
90,000 |
| 2022-02-18 |
Pontes Josias |
Acting Chief Financial Office |
RSU Award |
60,000 |
$1.48 |
$88.8K |
60,000 |
| 2022-02-18 |
Orfali May |
Chief Medical Officer |
RSU Award |
10,000 |
$1.48 |
$14.8K |
10,000 |
| 2022-01-03 |
Vivaldi Coelho Rogerio |
President and CEO |
RSU Award |
400,000 |
$3.03 |
$1.21M |
400,000 |
| 2022-01-03 |
Ashton-rickardt Philip |
Chief Scientific Officer |
RSU Award |
90,000 |
$3.03 |
$272.7K |
90,000 |
| 2022-01-03 |
Pontes Josias |
VP, Head of Finance |
RSU Award |
65,000 |
$3.03 |
$196.95K |
65,000 |
| 2022-01-03 |
Orfali May |
Chief Medical Officer |
RSU Award |
10,000 |
$3.03 |
$30.3K |
10,000 |
| 2021-12-01 |
Orfali May |
Chief Medical Officer |
RSU Award |
80,000 |
$3.14 |
$251.2K |
80,000 |
| 2021-11-29 |
Orfali May |
Officer |
Unknown |
- |
- |
- |
- |
| 2021-11-04 |
Vivaldi Coelho Rogerio |
President and CEO |
RSU Award |
50,000 |
- |
- |
73,461 |
| 2021-09-30 |
Pontes Josias |
VP, Head of Finance |
RSU Award |
11,500 |
- |
- |
13,339 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
